Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 3/2002

01-06-2002 | Announcement

Breast Cancer Research: the move to publish research articles in full online only

Author: Peter Newmark

Published in: Breast Cancer Research | Issue 3/2002

Login to get access

Excerpt

When Breast Cancer Research was launched in 1999 we took the innovative decision to make all primary research articles available to everyone for free through the journal's own website http://​breast-cancer-research.​com as well as through PubMed Central http://​www.​pubmedcentral.​nih.​gov/​, the National Institute of Health's repository for biomedical research articles, and through BioMed Central http://​biomedcentral.​com. This year we have taken the next logical step by deciding to publish research articles in full only online. …
Metadata
Title
Breast Cancer Research: the move to publish research articles in full online only
Author
Peter Newmark
Publication date
01-06-2002
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 3/2002
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr462

Other articles of this Issue 3/2002

Breast Cancer Research 3/2002 Go to the issue

Research article

Genetic determinants of mammographic density

Research article

Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer

Commentary

Liposome-based drug delivery in breast cancer treatment

Review

Knockout and transgenic mice of Trp53: what have we learned about p53 in breast cancer?

Commentary

Hormonal control of p53 and chemoprevention

Research article

Mutation analysis of the CHK2 gene in breast carcinoma and other cancers
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits